Gene · 27074
Papers3,205
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,205
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Highly sensitive and naked-eye detection of herpes simplex virus type 1 using LAMP- CRISPR/Cas12 diagnostic technology and gold nanoparticles. | Heliyon | 2023 | 38034811 | PubTator, text mining | PubMed |
| Transcriptome profiling of human col\onic cells exposed to the gut pathobiont Streptococcus gallolyticus subsp. gallolyticus. | PLoS One | 2023 | 38033043 | PubTator, text mining | PubMed |
| Diagnostic Values of METTL1-Related Genes and Immune Characteristics in Systemic Lupus Erythematosus. | J Inflamm Res | 2023 | 38026241 | PubTator, text mining | PubMed |
| Targeted down-regulation of SRSF1 exerts anti-cancer activity in OSCC through impairing lysosomal function and autophagy. | iScience | 2023 | 38025785 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy. | Front Oncol | 2023 | 38023214 | PubTator, text mining | PubMed |
| Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 38022729 | PubTator, text mining | PubMed |
| Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer. | Mediators Inflamm | 2023 | 38022687 | PubTator, text mining | PubMed |
| High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy. | J Immunother Cancer | 2023 | 38016720 | PubTator, text mining | PubMed |
| Deciphering tumor-infiltrating dendritic cells in the single-cell era. | Exp Hematol Oncol | 2023 | 38012715 | PubTator, text mining | PubMed |
| GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. | Genome Med | 2023 | 38008725 | PubTator, text mining | PubMed |
| TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment. | Cancer Cell Int | 2023 | 37986192 | PubTator, text mining | PubMed |
| Application of single-cell sequencing to the research of tumor microenvironment. | Front Immunol | 2023 | 37965341 | PubTator, text mining | PubMed |
| Langerhans cell histiocytosis: current advances in molecular pathogenesis. | Front Immunol | 2023 | 37965340 | PubTator, text mining | PubMed |
| Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. | Front Immunol | 2023 | 37965307 | PubTator, text mining | PubMed |
| Clinical biomarkers for Lewy body diseases. | Cell Biosci | 2023 | 37964309 | PubTator, text mining | PubMed |
| Dendritic Cell Subpopulations Are Associated with Prognostic Characteristics of Breast Cancer after Neoadjuvant Chemotherapy-An Observational Study. | Int J Mol Sci | 2023 | 37958800 | PubTator, text mining | PubMed |
| Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis. | Cell Commun Signal | 2023 | 37957625 | PubTator, text mining | PubMed |
| A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer. | BMC Cancer | 2023 | 37946136 | PubTator, text mining | PubMed |
| Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. | Nature | 2023 | 37938773 | PubTator, text mining | PubMed |
| Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study. | BMC Cancer | 2023 | 37936126 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27074/papers?page=18